Position in GSK
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$16,764,177
+$5,043,698 QoQ
Shares Held
319,805
+50.6% QoQ
Ownership
0.016%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#80
of 1,032 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 1%
Shared 99%
None 0%
Common Shares in GSK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026MASSACHUSETTS FINANCIAL SERVICES CO /MA/ holds $6,486,971,678 across 12 Drug Manufacturers - General names. GSK ranks #10 (0.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
10,539,098 | $2,676,614,716 | |
| 2 | PFE |
Pfizer Inc
|
56,551,011 | $1,361,748,341 | |
| 3 | ABBV |
AbbVie Inc.
|
4,388,338 | $1,104,281,370 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
6,651,833 | $840,392,576 | |
| 5 | LLY |
ELI LILLY & Co
|
145,790 | $174,864,912 | |
| 6 | BIIB |
Biogen Inc.
|
744,892 | $160,941,363 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
948,427 | $54,648,359 | |
| 8 | NVS |
Novartis AG
|
293,443 | $45,988,386 |
All Filings in GSK
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $16,764,177 | 319,805 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $11,720,479 | 212,366 | Shares | Defined | 2026-05-14 | |
| No filing history on record for this holder in this stock. | ||||||